NCT00489294View on ClinicalTrials.gov

Safety Study of Syntropin (Human Growth Hormone) for the Treatment of Growth Hormone Deficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Growth Hormone Deficiency
Interventions
DRUG

Syntropin

Trial Locations (1)

77402

Novum Pharmaceutical Research Services, Houston

Sponsors
All Listed Sponsors
lead

Phage Pharmaceuticals, Inc.

INDUSTRY